| Literature DB >> 34897560 |
Tobias Engeroff1, David A Groneberg2, Daniel Niederer3.
Abstract
BACKGROUND: Protection against airborne infection is currently, due to the COVID-19-associated restrictions, ubiquitously applied during public transport use, work and leisure time. Increased carbon dioxide re-inhalation and breathing resistance may result thereof and, in turn, may negatively impact metabolism and performance.Entities:
Keywords: Corona; Crisis; Dead space; Droplets; Sport; Upper airway infection
Year: 2021 PMID: 34897560 PMCID: PMC8665851 DOI: 10.1186/s40798-021-00388-6
Source DB: PubMed Journal: Sports Med Open ISSN: 2198-9761
Fig. 1Research, selection and synthesis of included studies. n, number; FFP, filtering face piece
Study characteristics of the included randomised controlled crossover studies
| References | Participants, number (n) (age in years, height in centimetres, weight in kilogrammes) [mean, SD] | Protocol (duration in minutes, intensity categorisation) | Mask types (surgical mask or FFP2/N95 type including manufacturer details) | Pulse-derived oxygen saturation in per cent | Heart rate in beats per minute | Transcutaneous carbon dioxide partial pressure in millimetres of mercury | Respiratory rate in breaths per minute | Ventilation in litres per minute | Oxygen uptake in millilitres per minute per kilogramme body weight | Carbon dioxide exhalation in millilitres per minute | Peak power in Watts | Secondary outcomes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean, standard deviation of mask condition (no mask control) | ||||||||||||
| Roberge et al. 2014 [ | age = 26.1, 4 height = 167.5, 5.9 weight = 67.5, 9.5 | Sitting (20 min; rest) | FFP2/N95 respirator without valve (flat folded or premould randomised) | 99.2, 0.7 (99.0, 0.7) | 73.7, 14.8 (70.6, 12.8) | 36.8, 3.1 (36.9, 3.0) | 17.3, 3.2 (17.8, 3.8) | Chest wall temperature, aural temperature | ||||
| Standing upright (20 min; rest) | 99.1, 0.6 (98.7, 1.6) | 78.6, 22.2 (76.9, 14.8) | 35.1, 8.4 (37.4, 4.6) | 17.2, 3.1 (17.3, 3.6) | ||||||||
| Cycle ergometer (20 min; low intensity) | 98.8, 0.7 (98.7, 1.2) | 105.5, 15.9 (98.8, 18.2) | 38.7, 3.1 (37.4, 3.3) | 24.9, 6.1 (26.4, 4.2) | ||||||||
| Li et al. 2021 [ | age = 21.1, 0.5 height = 157.0, 3.8 weight = 49.1, 2.5 | Cycle ergometer (Duration n.a.; graded until volitional exhaustion; vigorous intensity) | Surgical mask | 162.6, 21.7 (162.6, 17.7) | 43.2, 11.7 (51.8, 13.4) | 23.0, 5.5 (26.9, 4.9) | 195.6, 30.0 (197.6, 29.3) | Rating of perceived exertion (RPE) | ||||
age = 21.0, 1.6 height = 172.6 ± 4.5 weight = 59.4, 3.5 | 170.6, 11.3 (177.6, 10.5) | 62.6, 15.4 (74.0, 13.4) | 28.5, 4.9 (36.2, 3.8) | 184.8, 26.8 (187.0, 28.15) | ||||||||
| Kienbacher et al. 2021 [ | Basic life support (12 min; moderate intensity) | FFP2/N95 respirator without valve (Yao Wang Medical Protective Face Maskî, QingzhouYaowang Pharmaceuticals Co. Ltd., China); | 96.0, 2.7 (97.0, 2.7) | 110.0, 51.3 (105.0, 51.3) | Basic life support performance; blood pressure; RPE, end-tidal CO2 | |||||||
| FFP2/N95 respirator with valve (Meditrade Respima1 EECî, Meditrade1 GmbH, Germany) | 97.0, 2.7 (97.0, 2.7) | 108.0, 51.3 (105.0 51.3) | ||||||||||
| Fikenzer et al. 2020 [ | Cycle ergometer semi recumbent (16.8 ± 2.8; graded until volitional exhaustion; vigorous intensity) | Surgical mask (SuavelÆ Protec Plus, Meditrade, Kiefersfelden, Germany); | 183.0, 9.2 (187.0, 8.3) | 39.3, 6.2 (40.9, 5.1) | 114.0, 23.3 (131.0, 27.8) | 37.9, 6.0 (39.7, 5.8) | 269, 45 (277, 46) | 269, 45 (277, 46) | Body plethysmography, spiroergometric and haemodynamic parameters, subjective complaints | |||
| FFP2/N95 respirator without valve (ShaoguanTaijie Protection Technology Co., Ltd., Gao Jie, China) | 182.0, 11.2 (187.0, 8.3) | 36.8, 5.9 (40.9, 5.1) | 98.8, 18.6 (131.0, 27.8) | 34.5, 5.3 (39.7, 5.8) | 263, 42 (277, 46) | 263, 42 (277, 46) | ||||||
| Kim et al. 2016 [ | Treadmill walking (60 min; moderate intensity; 35 °C and 50% humidity) | FFP2/N95 respirator without valve (3 M model 1870 FFP2/N95 respirator FFR, 3 M, St Paul, MN) | 97.8, 0.6 (97.9, 1.1) | 105.9, 11.9 (106.2, 14.8) | 41.3, 2.4 (40.9, 2.4) | 28.4, 3.2 (28.1, 7.1) | Skin temperature, heat perception | |||||
| Lässing et al. 2020 [ | Cycle ergometer (30 min, vigorous intensity) | Surgical mask (Suavel Protec Plus, Meditrade, Kiefersfelden, Germany) | 95.3, 0.8 (95.2, 0.7) | 160.1, 11.2 (154.4, 11.4) | 32.1, 5.4 (34.0, 7.3) | 77.1, 9.3 (82.4, 10.6) | 33.1, 5.0 (34.5, 5.8) | 2575, 310 (2685, 278) | Body plethysmography, spiroergometric and haemodynamic parameters | |||
| Sammito et al. 2021 [ | Sitting (5 min, rest) | FFP2/N95 respirator without valve (Gitemk FFP2 protective mask, Zhejiang Yinghua Technology, China) | 97.4, 1.1 (96.7, 2.1) | 76.0, 9.5 (76.9, 6.3) | None | |||||||
| Epstein et al. 2020 [ | Cycle ergometer (16.3 ± 3.7; graded until volitional exhaustion; vigorous intensity) | FFP2/N95 respirator without valve (Duckbill style fluid shield 2 FFP2/N95 respirator particulate filter respirator, Halyard) | 97.6, 1.3 (98.1, 1.1) | 168.8, 12.8 (170.5, 11.7) | 36.6, 5.4 (36.7, 7.5) | 154, 30 (157, 31) | Rating of perceived exertion (Borg), blood pressure | |||||
| Surgical mask (Kimberly-Clark) | 97.7, 1.6 (98.1, 1.1) | 165.8, 16.0 (170.5, 11.7) | 36.2, 7.0 (36.7, 7.5) | 153, 31 (157, 31) | ||||||||
| Mapelli et al. 2021 [ | Cycle ergometer (duration n.a.; graded until volitional exhaustion; vigorous intensity) | FFP2/N95 respirator without valve (KFFP2/N95 respirator particulate respirator, BYD care, China) | 95.1, 3.1 (97.3, 1.2) | 167.0, 16.1 (170.0, 14.0) | 37.1, 4.5 (41.5, 8.0) | 71.6, 21.2 (92.3, 26.0) | 28.2, 8.8 (31.0, 6.7) | 2268, 794 (2578, 763) | 184, 54 (194, 57) | Spiroergometric data | ||
| Surgical mask (disposable medical mask, Aiminde, China) | 96.5, 1.2 (97.3, 1.2) | 168.0, 16.0 (170.0, 14.0) | 37.7, 5.5 (41.5, 8.0) | 76.2, 21.6 (92.3, 26.0) | 27.5, 6.9 (31.0, 6.7) | 2217, 691 (2578, 763) | 187, 54 (194, 57) | |||||
| Bertoli et al. 2021 [ | Lying down (no mask = 11.4 ± 2.7 min, mask 11.9 ± 2.2 min; rest) | FFP2/N95 respirator without valve (manufacturer details n.a.) | 3.0, 0.6 (2.9, 0.5) | 182, 37 (179, 34) | Energy expenditure | |||||||
| Person et al. 2018 [ | Walking (6 min; moderate intensity) | surgical mask (manufacturer details n.a | 98.3, 1.1 (98.3, 1.0) | 134.6, 22.9 (138.7, 23.6) | ||||||||
| Kim et al. 2015 [ | Standing upright (20 min, rest) | FFP2/N95 respirator without valve (3 M 9210 flat-fold model (3 M, St. Paul, MN) or a Moldex cup-shaped model in either medium/large size (Moldex2200) or small size (Moldex 2201) (Moldex, Culver City, CA)) | 99.1, 0.5 (98.5, 1.8) | 78.9, 15.5 (78.1, 15.6) | 37.4, 3.5 (38.1, 5.1) | Rating of perceived exertion, blood pressure | ||||||
| Cycle ergometer semirecumbent (20 min, low intensity) | 98.7, 0.6 (98.5, 1.3) | 101.9, 15.0 (97.1, 19.3) | 39.3, 3.2 (38.1, 3.4) | |||||||||
| Sitting (20 min, rest) | 99.1, 0.6 (98.9, 0.7) | 73.5, 10.6 (67.8, 12.5) | 37.4, 3.0 (37.3, 3.3) | |||||||||
| Shaw et al. 2020 [ | Cycle ergometer (10.3 ± 2.35 min; graded until volitional exhaustion; vigorous intensity) | Surgical mask CRC-Elm 5, Hawketree Solutions, Ottawa, ON, Canada | 96.0, 3,0 (96.0, 4.0) | 179.0, 19.0 (179.0, 16.0) | 241, 57 (234, 56) | Continuous-wave near-infrared spectroscopy (vastus lateralis right); rating of perceived exertion | ||||||
| Roberge et al. 2010 [ | Treadmill walking (60 min, low intensity) | FFP2/N95 respirator without valve (cup shaped, manufacturer details n.a.); | 98.1, 0.9 (98.5, 0.8) | 98.1, 8.5 (92.3, 8.2) | 39.7, 6.0 (40.7, 3.5) | 25.2, 4.0 (27.7, 7.1) | 23.4, 6.7 (20.9, 8.2) | Mask dead space gases, subjective complaints | ||||
| FFP2/N95 respirator with exhalation valve (cup shaped, manufacturer details n.a.) | 98.4, 1.0 (98.5, 0.8) | 95.1, 9.7 (92.3, 8.2) | 41.5, 4.9 (40.7, 3.5) | 25.2, 6.1 (27.7, 7.1) | 21.2, 4.5 (20.9, 8.2) | |||||||
| Treadmill walking (60 min, moderate intensity) | FFP2/N95 respirator without valve | 98.4, 0.7 (98.5, 0.8) | 106.4, 9.2 (101.3, 11.8) | 42.0, 5.6 (40.8, 3.2) | 26.6, 6.8 (27.7, 8.6) | 24.4, 6.0 (23.0, 6.5) | ||||||
| FFP2/N95 respirator with exhalation valve | 98.2, 1.0 (98.5, 0.8) | 106.4, 9.3 (101.3, 11.8) | 42.6, 6.2 (40.8, 3.2) | 25.5, 5.7 (27.7, 8.6) | 23.0, 5.9 (23.0, 6.5) | |||||||
Information on participants’ characteristics, intervention protocols and applied mask types, as well as descriptive key results and information on secondary outcomes not included, are displayed
Fig. 2Pooled effect size estimates (standardised mean differences) for the pulse-derived oxygen saturation and oxygen uptake outcomes. Overall effects for face mask application (surgery mask and FFP2/N95 with and without valve) in comparison with a comparator/no mask control are displayed. Effects for the subgroups are based on the grouping variables of different mask types (surgery mask or FFP2/N95 with and without valve) and the different types of physical activity (rest, low-, moderate- and vigorous intensity). SMD, standardised mean difference; CI, confidence interval
Fig. 3Pooled effect size estimates (standardised mean differences) for the transcutaneous carbon dioxide partial pressure and carbon dioxide exhalation outcomes. Overall effects for face mask application (surgery mask, FFP2/N95 with and without valve) in comparison with a comparator/no mask control are displayed. Subgroups were based on the grouping variables of different mask types (surgery mask, FFP2/N95 with and without valve) and the different types of physical activity (rest, low-, moderate- and vigorous intensity). SMD, standardised mean difference; CI, confidence interval
Fig. 4Pooled effect size estimates (standardised mean differences) for the respiratory rate and ventilation outcomes. Overall main effects for face mask application (surgery mask, FFP2/N95 with and without valve) in comparison with a comparator/no mask control, as well as the effects for subgroups based on the following grouping variables, are displayed: different mask types (surgery mask, FFP2/N95 with and without valve) and the different types of physical activity (rest, low-, moderate- and vigorous intensity). SMD, standardised mean difference; CI, confidence interval
Fig. 5Pooled effect size estimates (standardised mean differences) for the maximal heart rate and peak power outcomes during incremental exercise testing. Overall main effects for face mask application (surgery mask, FFP2/N95 with and without valve) in comparison with a comparator/no mask control and the effects for subgroups based on the following grouping variables are shown: different mask types (surgery mask, FFP2/N95 with and without valve) and the different types of physical activity (rest, low-, moderate- and vigorous intensity). SMD, standardised mean difference; CI, confidence interval
Outcomes of the meta-regression
| Mean effect size: 0.062; R2: 0.615; n effect sizes: 20 | |||||||
|---|---|---|---|---|---|---|---|
| Heterogeneity Q: 35.6 (df: 19, p = .01) | |||||||
| B | SE | 95%CI LL | 95%CI UL | Z | p value | Beta | |
| Intercept | 1.940 | 0.551 | 0.860 | 3.021 | 3.520 | 0.001 | 0.000 |
| Age (mean) [years] | − 0.042 | 0.016 | − 0.074 | − 0.010 | − 2.592 | 0.010 | − 0.485 |
| Exercise intensity (rest – low – moderate - vigorous) | − 0.179 | 0.062 | − 0.299 | − 0.058 | − 2.905 | 0.004 | − 0.561 |
| Mask type (surgery – FFP2/N95 without – FFP2/N95 with valve) | − 0.271 | 0.133 | − 0.532 | − 0.009 | − 2.029 | 0.043 | − 0.381 |
Effect sizes, number of included effect sizes, homogeneity, the regression coefficient B, its confidence interval (CI) and the corresponding p value are displayed
Fig. 6Risk of bias rating for each item, displayed as traffic light plots (above) and as summary bar plots (below). The colours indicate high (red), unclear (yellow) or low (green) risk for the respective bias domain/item
Fig. 7Funnel plot of all included studies. Each SMD (standard mean difference) and their corresponding SE (standard error) for pulse-derived oxygen saturation are plotted